In the article by Onuma et al (Onuma Y, Grundeken MJ, Nakatani S, Asano T, Sotomi Y, Foin N, Ng J, Okamura T, Wykrzykowska JJ, de Winter RJ, van Geuns RJ, Koolen J, Christiansen E, Whitbourn R, McClean D, Smits P, Windecker S, Ormiston JA, Serruys PW. Serial 5-year evaluation of side branches jailed by bioresorbable vascular scaffolds using 3-dimensional optical coherence tomography: insights from the ABSORB Cohort B trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Circ Cardiovasc Interv. 2017;10:9:e004393. DOI: 10.1161/CIRCINTERVENTIONS.116.004393.), which published online September 11, 2017, and appeared in the September 2017 issue of the journal, a correction was needed.
Dr Christiansen’s name should appear as Evald H. Christiansen.
This correction has been made to the article, which is available at http://circinterventions.ahajournals.org/content/10/9/e004393.
- © 2018 American Heart Association, Inc.